Status:
COMPLETED
Intracervical Lidocaine Gel for IUD Insertional Pain
Lead Sponsor:
Columbia University
Conditions:
Pain
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The intrauterine device (IUD) is a form of birth control that is extremely effective and safe, even in women who have not yet had children. Women can experience high levels of pain when the IUD is pla...
Detailed Description
The intrauterine device (IUD) is a highly effective, long-acting, reversible method of contraception used by approximately 8% of women in the developed world. In the United States, historically candid...
Eligibility Criteria
Inclusion
- Self-select either a Paragard or Mirena IUD and are appropriate for insertion as determined by their provider
- Age 18-45
- Speak English or Spanish
Exclusion
- Lidocaine allergy
- First trimester abortion or miscarriage in the previous six weeks
- Second trimester abortion or miscarriage in the previous 12 weeks
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01214161
Start Date
October 1 2010
End Date
June 1 2013
Last Update
April 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Family Planning Clinic / Columbia University Family Planning Practice
New York, New York, United States, 10032